- In April 2025, Copan Diagnostics launched an AI‑driven self-sampling nasal swab kit designed for at-home testing, integration with telehealth platforms, and enhanced diagnostic accuracy through secure digital traceability of samples. This innovation highlights the market’s shift toward decentralized healthcare delivery and improved patient autonomy
- In March 2025, Thermo Fisher Scientific unveiled a multi-specimen swab kit compatible with a single viral transport medium (VTM), enabling simultaneous collection of nasal, throat, and vaginal swabs. This system streamlines clinic workflows, reduces packaging waste, and lowers per-test costs
- In February 2025, Puritan Medical Products completed a new swab-manufacturing facility in North Carolina to bolster supply resilience and meet surges in global demand, emphasizing the industry's focus on speed and supply chain responsiveness
- In January 2025, BD (Becton, Dickinson and Company) introduced a flocked foam swab optimized for rapid antigen and molecular testing, featuring improved sample retention and stability even without refrigeration, catering to use in low-resource and remote settings
- In December 2024, Copan Diagnostics announced a strategic partnership with a global e-commerce provider to distribute sterile at-home throat and nasal swab kits, expanding direct-to-consumer reach and supporting mass testing during seasonal illness outbreaks
